Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
Clinical trial NCT02831231 · COMPLETED
Trial details
- NCT number
- NCT02831231
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-07
- Primary completion
- 2016-10-28
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.